Cell MedX Corp. (CMXC) financial statements (2022 and earlier)

Company profile

Business Address 123 W. NYE LN, SUITE 446
CARSON CITY, NV 89706
State of Incorp. NV
Fiscal Year End May 31
SIC 59 - Miscellaneous Retail (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

11/30/2021
Q2
8/31/2021
Q1
5/31/2021
Q4
2/28/2021
Q3
11/30/2020
Q2
8/31/2020
Q1
5/31/2020
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments376421262212045
Cash and cash equivalents376421262212045
Inventory, net of allowances, customer advances and progress billings   48535452
Inventory   48535452
Other current assets35383024216160
Total current assets:72101519896236157
Noncurrent Assets
Property, plant and equipment0112232
Total noncurrent assets:0112232
TOTAL ASSETS:731025210098239159
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities421427467455401423943
Accounts payable416397432450391392909
Accrued liabilities431355103035
Due to related parties888851818777734711234
Total current liabilities:1,3091,2781,2851,2321,1351,1341,177
Noncurrent Liabilities
Other undisclosed liabilities472378344757646592502
Total liabilities:1,7811,6561,6281,9901,7811,7261,680
Stockholders' equity
Stockholders' equity attributable to parent(2,075)(1,921)(1,943)(2,256)(2,050)(1,854)(1,887)
Common stock63636259595956
Common stock, value, subscriptions      80
Additional paid in capital7,2737,2737,0766,3566,3566,3565,988
Accumulated other comprehensive income (loss)(35)(56)(121)(52)(25)(18)39
Accumulated deficit(9,376)(9,200)(8,960)(8,619)(8,440)(8,251)(8,050)
Other undisclosed stockholders' equity366366366366366366366
Total stockholders' equity:(1,709)(1,554)(1,576)(1,890)(1,684)(1,487)(1,520)
TOTAL LIABILITIES AND EQUITY:731025210098239159

Income statement (P&L) ($ in thousands)

11/30/2021
Q2
8/31/2021
Q1
5/31/2021
Q4
2/28/2021
Q3
11/30/2020
Q2
8/31/2020
Q1
5/31/2020
Q4
Revenues    2156
Cost of revenue(1)(0)1(3)(1)(0)(10)
Cost of goods and services sold(1)(0)1(3)(1)(0) 
Other undisclosed gross profit21(1)4  8
Gross profit:11(0)21154
Operating expenses(171)(235)(179)(172)(182)(196)(1,948)
Operating loss:(171)(234)(179)(170)(181)(195)(1,894)
Nonoperating income (expense)2164(68)(27)(7)(57)20
Foreign currency transaction gain (loss), before tax2164(68)(27)(7)(57)20
Interest and debt expense(5)(5)(162)(9)(8)(6)63
Loss from continuing operations before income taxes:(154)(175)(410)(206)(197)(258)(1,811)
Other undisclosed income from continuing operations  191   229
Loss before gain (loss) on sale of properties:(154)(175)(218)(206)(197)(258)(1,582)
Other undisclosed net income (loss)(21)(64)(32)27 571,399
Net loss:(176)(239)(250)(179)(197)(201)(183)
Other undisclosed net income (loss) attributable to parent  (91) 7  
Net loss available to common stockholders, diluted:(176)(239)(341)(179)(189)(201)(183)

Comprehensive Income ($ in thousands)

11/30/2021
Q2
8/31/2021
Q1
5/31/2021
Q4
2/28/2021
Q3
11/30/2020
Q2
8/31/2020
Q1
5/31/2020
Q4
Net loss:(176)(239)(250)(179)(197)(201)(183)
Comprehensive loss:(176)(239)(250)(179)(197)(201)(183)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent2164(159)(27) (57)20
Comprehensive loss, net of tax, attributable to parent:(154)(175)(410)(206)(197)(258)(163)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: